Linkingin VitroLipolysis and Microsomal Metabolism for the Quantitative Prediction of Oral Bioavailability of BCS II Drugs Administered in Lipidic Formulations
Molecular Pharmaceutics - United States
doi 10.1021/acs.molpharmaceut.6b00597
Full Text
Open PDFAbstract
Available in full text
Date
September 2, 2016
Authors
Publisher
American Chemical Society (ACS)